World's Best Scientists 2026 revealed!
VIEW LIST
Mark C. Genovese

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 98 8812 8270 4539 4198 481 43664

Mark C. Genovese publications per year

The chart shows the history of publications by Mark C. Genovese between 1991 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Mark C. Genovese published across 35 years, from 1991 to 2025, averaging 14.2 papers a year. Output peaked at 60 publications in 2013. 6 of the 496 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1991 to 2025. Vertical axis: number of publications, 0 to 60. Peak 60 publications in 2013. 1991: 1 publication 1992: 1 publication 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 2 publications 1998: 1 publication 1999: 1 publication 2000: 3 publications 2001: 10 publications 2002: 9 publications 2003: 10 publications 2004: 11 publications 2005: 13 publications 2006: 9 publications 2007: 12 publications 2008: 5 publications 2009: 14 publications 2010: 9 publications 2011: 23 publications 2012: 22 publications 2013: 60 publications 2014: 25 publications 2015: 24 publications 2016: 34 publications 2017: 28 publications 2018: 32 publications 2019: 40 publications 2020: 57 publications 2021: 17 publications 2022: 8 publications 2023: 9 publications 2024: 4 publications 2025: 2 publications
1991 2025

496 publications in total across all disciplines

View publications per year as a table
Mark C. Genovese: publications per year, 1991 to 2025
Year Publications
1991 1
1992 1
1993 0
1994 0
1995 0
1996 0
1997 2
1998 1
1999 1
2000 3
2001 10
2002 9
2003 10
2004 11
2005 13
2006 9
2007 12
2008 5
2009 14
2010 9
2011 23
2012 22
2013 60
2014 25
2015 24
2016 34
2017 28
2018 32
2019 40
2020 57
2021 17
2022 8
2023 9
2024 4
2025 2
Total 496
Download as CSV

Mark C. Genovese publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark C. Genovese sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 481–500 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 481 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713 481
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Mark C. Genovese D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark C. Genovese sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 98–99 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668 98
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Mark C. Genovese is an active researcher affiliated with Stanford University in the United States. Their work focuses predominantly on the field of medicine, with a strong emphasis on rheumatology, genetics, pathology and forensic medicine, hematology, and immunology.

The researcher has contributed extensively to the study of rheumatoid arthritis, chronic lymphocytic leukemia, lymphoma diagnosis and treatment, autoimmune and inflammatory disorders, biosimilars and bioanalytical methods, systemic lupus erythematosus, and chronic myeloid leukemia treatments.

Some of their recent publications include:

  • Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study (2020, The Lancet Rheumatology)
  • Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (2020, Arthritis & Rheumatology)
  • Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial (2021, Annals of the Rheumatic Diseases)
  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis (2021, Arthritis Care & Research)
  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis (2021, Arthritis & Rheumatology)

Mark C. Genovese frequently collaborates with other researchers in the field. Frequent co-authors include:

  • Kevin Winthrop
  • Tsutomu Takeuchi
  • Gerd R Burmester
  • R. Besuyen
  • Beatrix Bartók

Their work appears regularly in several leading publication venues, demonstrating a consistent presence in the academic community. These venues include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Arthritis & Rheumatology
  • The Lancet Rheumatology
  • Arthritis Research & Therapy

Best Publications

  • Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy : Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

    Stanley B Cohen;Paul Emery;Maria W Greenwald;Maxime Dougados

  • A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

    Joan M. Bathon;Richard W. Martin;Roy M. Fleischmann;John R. Tesser

  • Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.

    Mark C Genovese;Jean-Claude Becker;Michael Schiff;Michael Luggen

  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Liana Fraenkel;Joan M Bathon;Bryant R England;E William St Clair

  • Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.

    Mark C. Genovese;James D. McKay;Evgeny L. Nasonov;Eduardo F. Mysler

  • Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: The AMBITION study

    Graeme Jones;Anthony Sebba;Jieruo Gu;Mitchell B Lowenstein

  • Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.

    Mark C. Genovese;Joan M. Bathon;Richard W. Martin;Roy M. Fleischmann

  • Autoantigen microarrays for multiplex characterization of autoantibody responses

    William H. Robinson;Carla DiGennaro;Wolfgang Hueber;Brian B. Haab

  • Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.

    Mark C. Genovese;Stanley Cohen;Larry Moreland;Deborah Lium

  • Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

    Edward C. Keystone;Mark C. Genovese;Lars Klareskog;Elizabeth C. Hsia

  • Baricitinib in Patients with Refractory Rheumatoid Arthritis

    Mark C. Genovese;Joel Kremer;Omid Zamani;Charles Ludivico

  • LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis a phase I randomized, double-blind, placebo-controlled, proof-of-concept study

    M. C. Genovese;F. Van den Bosch;S. A. Roberson;S. Bojin

  • Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity.

    Eric J. Kunkel;James J. Campbell;Guttorm Haraldsen;Junliang Pan

  • Rules of chemokine receptor association with T cell polarization in vivo

    Chang H. Kim;Lusijah Rott;Eric J. Kunkel;Mark C. Genovese

  • An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

    Michael E. Weinblatt;Arthur Kavanaugh;Mark C. Genovese;Theresa K. Musser

  • Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

    Joel M. Kremer;Mark C. Genovese;Grant W. Cannon;Jacques R. Caldwell

  • Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs.

    Roy Fleischmann;Maurizio Cutolo;Mark C. Genovese;Eun Bong Lee

  • Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial.

    Joel Kremer;Zhan-Guo Li;Stephen Hall;Roy Fleischmann

  • Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis

    Philip J. Mease;Mark C. Genovese;Maria W. Greenwald;Christopher T. Ritchlin

  • Bonzo/CXCR6 expression defines type 1–polarized T-cell subsets with extralymphoid tissue homing potential

    Chang H. Kim;Eric J. Kunkel;Judie Boisvert;Brent Johnston

Frequent Co-Authors

Roy Fleischmann
Roy Fleischmann The University of Texas Southwestern Medical Center
Michael E. Weinblatt
Michael E. Weinblatt Brigham and Women's Hospital
Edward C. Keystone
Edward C. Keystone University of Toronto
Paul Emery
Paul Emery University of Leeds
Joel M. Kremer
Joel M. Kremer Albany Medical Center Hospital
Alan J. Kivitz
Alan J. Kivitz Altoona Arthritis and Osteoporosis Center
Josef S. Smolen
Josef S. Smolen Medical University of Vienna
Gerd R. Burmester
Gerd R. Burmester Charité - University Medicine Berlin
William H. Robinson
William H. Robinson Stanford University
Kevin L. Winthrop
Kevin L. Winthrop Oregon Health & Science University

External Links

Personal website of Mark C. Genovese

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options beyond a traditional MD in the USA? Many students are considering related online degrees that open doors to healthcare leadership, pharmacy, nursing, and informatics roles. Completing your degree online allows for greater flexibility while balancing work or family commitments.

A major consideration for students is the cost of mha degree, particularly as tuition rates can vary widely. For those interested in advanced nursing, there are dnp online programs cheap that offer affordable routes to becoming a Doctor of Nursing Practice without the expense of on-campus study.

Aspiring pharmacists can take advantage of quality online pharmacy school programs to earn their credentials while studying remotely. Additionally, students interested in medical coding, data management, or digital health can enroll in rhit programs online to prepare for careers in health information management.

Overall, these online healthcare degrees provide accessible and cost-effective pathways to rewarding medical and healthcare careers in the USA.

Best Scientists Citing Mark C. Genovese

Paul Emery

Paul Emery

University of Leeds

Publications: 227

Yoshiya Tanaka

Yoshiya Tanaka

University of Occupational and Environmental Health Japan

Publications: 142

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 120

William H. Robinson

William H. Robinson

Stanford University

Publications: 115

Roy Fleischmann

Roy Fleischmann

The University of Texas Southwestern Medical Center

Publications: 104

Iain B. McInnes

Iain B. McInnes

University of Glasgow

Publications: 102

Tsutomu Takeuchi

Tsutomu Takeuchi

Keio University

Publications: 102

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 94

Arthur Kavanaugh

Arthur Kavanaugh

University of California, San Diego

Publications: 88

Paul P. Tak

Paul P. Tak

GlaxoSmithKline (United Kingdom)

Publications: 86

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 82

Philip J. Mease

Philip J. Mease

University of Washington

Publications: 81

Ronald F. van Vollenhoven

Ronald F. van Vollenhoven

University of Amsterdam

Publications: 80

Edward C. Keystone

Edward C. Keystone

University of Toronto

Publications: 80

Daniel E. Furst

Daniel E. Furst

University of California, Los Angeles

Publications: 74

Vibeke Strand

Vibeke Strand

Stanford University

Publications: 72

Trending Scientists

Magnus Berggren

Magnus Berggren

Linköping University

James A. Forrest

James A. Forrest

University of Waterloo

Donald Penner

Donald Penner

Michigan State University

Rainer Reisenzein

Rainer Reisenzein

University of Greifswald

John A. Peacock

John A. Peacock

University of Edinburgh

Espen Dietrichs

Espen Dietrichs

Oslo University Hospital

Stephen M. Strittmatter

Stephen M. Strittmatter

Yale University

Trent R. Northen

Trent R. Northen

Lawrence Berkeley National Laboratory

Marcos González-Gaitán

Marcos González-Gaitán

University of Geneva

Celso C. Ribeiro

Celso C. Ribeiro

Fluminense Federal University

Demetrio Labate

Demetrio Labate

University of Houston

John R. Regalbuto

John R. Regalbuto

University of South Carolina

Guowang Diao

Guowang Diao

Yangzhou University

Guillermo E. Umpierrez

Guillermo E. Umpierrez

Emory University

Michael J. Wisdom

Michael J. Wisdom

US Forest Service

Edward E. Louis

Edward E. Louis

University of Leicester

Related Medicine Rankings & Guides

2027 Easiest Nurse Midwife Programs to Get Into

2027 Easiest Nurse Midwife Programs to Get Into
2027 Best Nurse Practitioner Programs in South Carolina – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in South Carolina – Accredited Schools Online & Campus
2027 Healthcare Degree Programs You Can Earn in 2 Years or Less

2027 Healthcare Degree Programs You Can Earn in 2 Years or Less
2027 Best Online Medical Assistant Associate Degree Programs

2027 Best Online Medical Assistant Associate Degree Programs
2027 Best Nurse Practitioner Programs in North Carolina – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in North Carolina – Accredited Schools Online & Campus
2027 Best Online Master’s in Clinical Research Programs

2027 Best Online Master’s in Clinical Research Programs
2027 Best Online MSN in Health/Nursing Informatics Programs

2027 Best Online MSN in Health/Nursing Informatics Programs
2027 Best Online Master of Health Administration (MHA) Programs

2027 Best Online Master of Health Administration (MHA) Programs
2027 Best Online MSN/MBA Dual Degree Programs

2027 Best Online MSN/MBA Dual Degree Programs
2027 Best Second-Degree BSN Programs

2027 Best Second-Degree BSN Programs
2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs
2027 Best Nursing Schools in Ohio – Accredited ADN, BSN & MSN Programs

2027 Best Nursing Schools in Ohio – Accredited ADN, BSN & MSN Programs
2027 Is Grand Canyon University School of Nursing Worth It?

2027 Is Grand Canyon University School of Nursing Worth It?
2027 Fastest Online Adult-Gerontology PCNP Graduate Certificate Programs

2027 Fastest Online Adult-Gerontology PCNP Graduate Certificate Programs
2027 Most Affordable Online Master's Degrees in Nutrition

2027 Most Affordable Online Master's Degrees in Nutrition
2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs
2027 Best Online Sonography Programs

2027 Best Online Sonography Programs
2027 Best Online Medical & Healthcare Certificate Programs

2027 Best Online Medical & Healthcare Certificate Programs
2027 Best Occupational Therapy Programs

2027 Best Occupational Therapy Programs
2027 Easiest Direct-Entry MSN Programs to Get Into

2027 Easiest Direct-Entry MSN Programs to Get Into
2027 Best Paramedic-to-RN Bridge Programs

2027 Best Paramedic-to-RN Bridge Programs

Recently Published Articles

2027 Clinical Psychology Degree Careers That Do Not Require Graduate School

2027 Clinical Psychology Degree Careers That Do Not Require Graduate School
2027 Cheapest Online Artificial Intelligence Master's Degrees That Pay Well: Tuition, Duration, and Earnings

2027 Cheapest Online Artificial Intelligence Master's Degrees That Pay Well: Tuition, Duration, and Earnings
2027 Industrial-Organizational Psychology vs. Human Resources Degree: Explaining the Difference

2027 Industrial-Organizational Psychology vs. Human Resources Degree: Explaining the Difference
2027 How to Become a BCBA in Los Angeles, CA: Education Requirements & Certification

2027 How to Become a BCBA in Los Angeles, CA: Education Requirements & Certification
2027 Competency-Based Online Data Science Master's Degrees

2027 Competency-Based Online Data Science Master's Degrees
2027 Public Administration Degree Guide: Costs, Requirements & Job Opportunities

2027 Public Administration Degree Guide: Costs, Requirements & Job Opportunities
2027 How to Become a Food Scientist: Education, Salary, and Job Outlook

2027 How to Become a Food Scientist: Education, Salary, and Job Outlook
2027 MSN Programs for Working Full-Time Nurses

2027 MSN Programs for Working Full-Time Nurses
2027 Shortest Online Cybercrime Degree Master's Programs That Pay Well: Cost, Time to Completion, and Salary Outlook

2027 Shortest Online Cybercrime Degree Master's Programs That Pay Well: Cost, Time to Completion, and Salary Outlook
2027 AI Bachelor's vs Computer Science Bachelor's: What Should You Choose?

2027 AI Bachelor's vs Computer Science Bachelor's: What Should You Choose?
2027 AI Master's Degrees for Project Managers

2027 AI Master's Degrees for Project Managers
2027 What are the Easiest and Lowest Stress Nursing Jobs?

2027 What are the Easiest and Lowest Stress Nursing Jobs?
2027 Best Online Master's in Organizational Leadership With Leadership Coaching Tracks

2027 Best Online Master's in Organizational Leadership With Leadership Coaching Tracks
2027 Hardest and Easiest Courses in a Mathematics Degree Program

2027 Hardest and Easiest Courses in a Mathematics Degree Program
2027 Can You Finish Faster at Southern Utah University With Transfer Credits?

2027 Can You Finish Faster at Southern Utah University With Transfer Credits?
2027 Best Online Auditing Doctorate Programs for Consulting Careers

2027 Best Online Auditing Doctorate Programs for Consulting Careers
2027 Best Online ABA Certificate Programs for BCBA Eligibility

2027 Best Online ABA Certificate Programs for BCBA Eligibility
2027 Radiologic vs. Nuclear Medicine Tech: Explaining the Difference

2027 Radiologic vs. Nuclear Medicine Tech: Explaining the Difference
2027 How to Become a Neonatal Nurse – Salary & Requirements

2027 How to Become a Neonatal Nurse – Salary & Requirements
2027 Online Crime Analysis Degree Master's Programs That Meet State Licensure Requirements

2027 Online Crime Analysis Degree Master's Programs That Meet State Licensure Requirements
2027 International Relations Degree Coursework Explained: What Classes Can You Expect to Take?

2027 International Relations Degree Coursework Explained: What Classes Can You Expect to Take?